Geor R J, Weiss D J, Burris S M, Smith C M
Department of Clinical and Population Sciences, College of Veterinary Medicine, University of Minnesota, St Paul 55108.
Am J Vet Res. 1992 Nov;53(11):2043-9.
The effects of furosemide and pentoxifylline on blood flow properties in horses were investigated. Hematologic and rheologic changes were examined in 4 horses before and 3 minutes after administration of epinephrine (1 mg, IV). The next day, hemorheologic changes were determined before and 3 hours after administration of furosemide (1 mg/kg of body weight, IM), and after administration of epinephrine at the sampling at 3 hours. Hematologic and rheologic changes were evaluated weekly in 3 horses given pentoxifylline (8.5 mg/kg, q 12 h, PO) for 28 days. In addition, hemorheologic responses to epinephrine were determined on days 0, 14, and 28 of pentoxifylline treatment. Neutrophil filtration studies were also performed 2 hours after IV administration of pentoxifylline (8.5 mg/kg). Postepinephrine values for PCV, RBC and WBC counts, and blood viscosity were greater than preepinephrine values. Erythrocyte sedimentation rates decreased after epinephrine, whereas RBC filterability did not change. Treatment with furosemide was associated with increases in mean RBC hemoglobin concentration and blood viscosity. Filterability of RBC did not change. Treatment with pentoxifyllie resulted in an increase in RBC filterability and erythrocyte sedimentation rate and a decrease in PCV; however, mean values for hematocrit and RBC count did not change. Treatment with pentoxifylline did not result in a change in resting blood viscosity, but markedly reduced the postepinephrine increase in blood viscosity. Neither IV nor orally administered pentoxifylline had an effect on neutrophil filtration. It was concluded that pentoxifylline has beneficial effects on RBC filterability and postepinephrine changes in blood viscosity, which may contribute to improvements of microcirculatory blood flow. In addition, furosemide may exacerbate exercise-associated hyperviscosity in horses.
研究了速尿和己酮可可碱对马血流特性的影响。在4匹马静脉注射肾上腺素(1毫克)前及注射后3分钟,检测血液学和流变学变化。次日,在肌肉注射速尿(1毫克/千克体重)前及注射后3小时,以及在3小时采样时注射肾上腺素后,测定血液流变学变化。对3匹马连续28天口服己酮可可碱(8.5毫克/千克,每12小时一次),每周评估血液学和流变学变化。此外,在己酮可可碱治疗的第0、14和28天,测定对肾上腺素的血液流变学反应。在静脉注射己酮可可碱(8.5毫克/千克)2小时后,也进行了中性粒细胞过滤研究。肾上腺素注射后,红细胞压积、红细胞计数和白细胞计数以及血液粘度的数值均高于注射前。肾上腺素注射后红细胞沉降率降低,而红细胞滤过率未改变。速尿治疗使平均红细胞血红蛋白浓度和血液粘度增加。红细胞滤过率未改变。己酮可可碱治疗使红细胞滤过率和红细胞沉降率增加,红细胞压积降低;然而,血细胞比容和红细胞计数的平均值未改变。己酮可可碱治疗未导致静息血液粘度改变,但显著降低了肾上腺素注射后血液粘度的增加。静脉注射和口服己酮可可碱均对中性粒细胞过滤无影响。得出的结论是,己酮可可碱对红细胞滤过率和肾上腺素注射后血液粘度的变化具有有益作用,这可能有助于改善微循环血流。此外,速尿可能会加重马运动相关的高粘度血症。